---
figid: PMC3399380__CHRP2012-648965.002
figtitle: IGF-IR signaling pathway
organisms:
- Homo sapiens
- clinical samples
pmcid: PMC3399380
filename: CHRP2012-648965.002.jpg
figlink: /pmc/articles/PMC3399380/figure/fig2/
number: F2
caption: IGF-IR signaling pathway. Increased expression of IGF-IR, or IGF-IR interaction
  and crosstalk with HER2 have been reported in models of Herceptin resistance. PI3K
  signaling has been implicated as a potential mechanism of IGF-IR-mediated Herceptin
  resistance. Inhibition of IGF-IR has been shown to increase sensitivity to Herceptin
  in preclinical studies.
papertitle: Deciphering the Role of Insulin-Like Growth Factor-I Receptor in Trastuzumab
  Resistance.
reftext: Rita Nahta. Chemother Res Pract. 2012;2012:648965.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9251379
figid_alias: PMC3399380__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC3399380__F2
ndex: 8647a2a2-df0a-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3399380__CHRP2012-648965.002.html
  '@type': Dataset
  description: IGF-IR signaling pathway. Increased expression of IGF-IR, or IGF-IR
    interaction and crosstalk with HER2 have been reported in models of Herceptin
    resistance. PI3K signaling has been implicated as a potential mechanism of IGF-IR-mediated
    Herceptin resistance. Inhibition of IGF-IR has been shown to increase sensitivity
    to Herceptin in preclinical studies.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1
  - ERBB2
  - IGF1R
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - KRAS
  - HRAS
  - NRAS
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - XYLT2
  - SOS1
  - SOS2
  - GRB2
  - IRS1
  - MTOR
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAPK3
  - MAPK1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
